Ocular Oncology and Treatments
Moving in Ophthalmology, Nature Communications, bioRxiv, Clinical Cancer Research, Genetics in Medicine, JNCI: Journal of the National Cancer Institute, Journal of Clinical Oncology and Science Signaling.
- Moved, week to 17 Nov 2026
- 0
- Papers in 60 days
- 33
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Ocular Oncology and Treatments
Newest first · last 60 days
AI summary · may contain errors
In uveal melanoma cells, Gq-coupled GPCRs (including HTR2B) enhance oncogenic signaling of Gαq Q209L, and HTR2B antagonists shift endogenous Gαq QL/QP toward inactivity.
AI summary · may contain errors
Occupational solar UVR exposure shows some non-monotonic positive association with incident ocular melanoma in the Norwegian Nor-Work cohort, with IRRs up to 1.80.
- Open access
AI summary · may contain errors
Genotype-Restricted Likelihood estimates cumulative risks by age for heterozygous germline BAP1 (likely) pathogenic variant carriers, reaching 58.6% for breast cancer by 80 years.
AI summary · may contain errors
Retinoblastoma is largely curable yet shows major global disparities, with the highest burden and mortality in regions with a low sociodemographic index.
AI summary · may contain errors
BAP1 loss in the GNAQ Q209L mouse uveal melanoma model is linked to fewer and smaller melanocytic lung lesions with Bap1flox/KO, but to macroscopic liver lesions with heterozygous loss.
- Open access
- 5 cites
AI summary · may contain errors
In first-line metastatic uveal melanoma, darovasertib plus crizotinib produced an overall response rate of 34.1% and median overall survival of 21.1 months in 44 treatment-naïve patients.
- Open access
AI summary · may contain errors
In 170 patients with choroidal melanoma treated with palladium-103 plaque brachytherapy, local tumor control was 100% with 20/200-or-better vision retained in 63.7% at 20 years.
- Open access
AI summary · may contain errors
Longitudinal RB1 ctDNA VAF in plasma is linked to extraocular retinoblastoma in 4/33 intraocular patients, with rising plasma VAF marking those who developed spread.
AI summary · may contain errors
Roginolisib, a conformation-selective PI3Kδ inhibitor, showed no dose-limiting toxicity in 44 advanced cancer patients, with Grade 3 toxicities at 6.8%.
- Open access
AI summary · may contain errors
p300 (EP300) is a top synthetic lethal vulnerability in GNAQ-mutant uveal melanoma, with CREBBP (CBP) also ranking among the strongest hits.
- Open access
Browse JClub
Journals this month
- bioRxiv6412
- medRxiv1763
- PNAS556
- JAMA353
- Sci Adv330
- Cell Rep315
- Environ Res225
- BMJ217
- EHJ206
- Nat Commun172
- NAR172
- Plant Cell Environ167
- Environ Pollution153
- Science152
- Curr Biol148
- NEJM148
- New Phytol147
- Nature128
Topics moving, week to 17 Nov 2026
- Single-cell and spatial transcriptomics10
- Gut microbiota and health6
- CAR-T cell therapy research6
- Pancreatic and Hepatic Oncology Research5
- Genomics and Chromatin Dynamics5
- Inflammatory Bowel Disease5
- Lung Cancer Treatments and Mutations5
- Antibiotic Resistance in Bacteria5
- Genomics and Phylogenetic Studies4
- Lipoproteins and Cardiovascular Health4
By field
- General Science & Medicine22
- Clinical Medicine25
- Cardiology & Vascular Biology12
- Endocrinology & Metabolism10
- Gastroenterology & Hepatology7
- Public & Global Health4
- Cell & Molecular Biology30
- Immunology & Inflammation14
- Neuroscience14
- Psychiatry & Mental Health8
- Genomics & Bioinformatics29
- Pharmacology & Drug Discovery5
- Microbiology & Mycology34
- Oncology22
- Ecology & Evolution5
- Protected Cropping & Horticultural Science5
- Plant Physiology & Photobiology19
- Student Research1
